Urine Pentacarboxyporphyrin

This test measures pentacarboxyporphyrin in a urine sample. Pentacarboxyporphyrin is one of several porphyrins, which are intermediates in the pathway your body uses to make heme, a key component of hemoglobin and other proteins. Porphyrins can build up when enzymes in this pathway are not working properly or when the liver or bile system is under stress.

Results are reported relative to urine creatinine to account for how diluted or concentrated the urine is. This measurement is typically performed as part of a fractionated porphyrin profile, which looks at several porphyrin types to help pinpoint the source of an abnormality.

Clinicians use urine pentacarboxyporphyrin to help evaluate suspected porphyrias, a group of metabolic conditions that can cause skin sensitivity, blistering, abdominal pain, and nerve symptoms. Patterns across different porphyrin fractions can suggest specific types of porphyria and guide further testing and treatment.

The test can also reflect non-porphyria conditions, especially those affecting the liver or bile flow. Certain medications, alcohol use, and other medical issues can influence porphyrin levels. Your clinician may order this test when symptoms, exam findings, or other labs point toward a porphyrin disorder or to monitor known disease.

Your result is interpreted alongside other porphyrin fractions, clinical history, and additional tests. A normal or very low result is expected in healthy individuals. An isolated or disproportionate increase can help narrow the cause, since different porphyrias and liver conditions produce characteristic porphyrin patterns.

If your result is higher than expected, your clinician may review medications and exposures, assess liver health, and consider confirmatory tests such as plasma fluorescence scanning, fecal porphyrins, urinary ALA and PBG, or genetic testing. Results do not diagnose a condition on their own, so follow-up focuses on your symptoms, medical history, and a stepwise testing plan.